These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 17550211)
1. Functional ovarian hyperandrogenism and polycystic ovary syndrome in prepubertal girls with obesity and/or premature pubarche. Siklar Z; Oçal G; Adiyaman P; Ergur A; Berberoğlu M J Pediatr Endocrinol Metab; 2007 Apr; 20(4):475-81. PubMed ID: 17550211 [TBL] [Abstract][Full Text] [Related]
2. Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset. Ibáñez L; de Zegher F; Potau N J Endocrinol Invest; 1998 Oct; 21(9):558-66. PubMed ID: 9856410 [TBL] [Abstract][Full Text] [Related]
4. Insulin resistance, obesity, hypofibrinolysis, hyperandrogenism, and coronary heart disease risk factors in 25 pre-perimenarchal girls age < or =14 years, 13 with precocious puberty, 23 with a first-degree relative with polycystic ovary syndrome. Glueck CJ; Morrison JA; Wang P J Pediatr Endocrinol Metab; 2008 Oct; 21(10):973-84. PubMed ID: 19209619 [TBL] [Abstract][Full Text] [Related]
5. Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism. Ibanez L; Potau N; Zampolli M; Prat N; Virdis R; Vicens-Calvet E; Carrascosa A J Clin Endocrinol Metab; 1996 Mar; 81(3):1237-43. PubMed ID: 8772605 [TBL] [Abstract][Full Text] [Related]
6. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. Ibañez L; Potau N; Virdis R; Zampolli M; Terzi C; Gussinyé M; Carrascosa A; Vicens-Calvet E J Clin Endocrinol Metab; 1993 Jun; 76(6):1599-603. PubMed ID: 8501168 [TBL] [Abstract][Full Text] [Related]
7. Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence. Ibáñez L; López-Bermejo A; Díaz M; Marcos MV; de Zegher F J Clin Endocrinol Metab; 2011 Aug; 96(8):E1262-7. PubMed ID: 21632811 [TBL] [Abstract][Full Text] [Related]
8. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. Rosenfield RL; Ehrmann DA Endocr Rev; 2016 Oct; 37(5):467-520. PubMed ID: 27459230 [TBL] [Abstract][Full Text] [Related]
9. The roles of insulin sensitivity, insulin-like growth factor I (IGF-I), and IGF-binding protein-1 and -3 in the hyperandrogenism of African-American and Caribbean Hispanic girls with premature adrenarche. Vuguin P; Linder B; Rosenfeld RG; Saenger P; DiMartino-Nardi J J Clin Endocrinol Metab; 1999 Jun; 84(6):2037-42. PubMed ID: 10372707 [TBL] [Abstract][Full Text] [Related]
11. Serum leptin levels in premature pubarche and prepubertal girls with and without obesity. Teixeira RJ; Ginzbarg D; Rodrigues Freitas J; Fucks G; Silva CM; Bordallo MA J Pediatr Endocrinol Metab; 2004 Oct; 17(10):1393-8. PubMed ID: 15526717 [TBL] [Abstract][Full Text] [Related]
12. [Polycystic ovary syndrome in pubertal period: clinical, biological, metabolic and genetic polymorphism]. Trimèche S; Thuan Dit Dieudonne JF; Jeandel C; Paris F; Simoni-Brum I; Orio F; Sultan C Gynecol Obstet Fertil; 2004 Jan; 32(1):3-17. PubMed ID: 14736594 [TBL] [Abstract][Full Text] [Related]
13. Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment. Ibáñez L; Valls C; Marcos MV; Ong K; Dunger DB; De Zegher F J Clin Endocrinol Metab; 2004 Sep; 89(9):4331-7. PubMed ID: 15356029 [TBL] [Abstract][Full Text] [Related]
14. Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood. Rosenfield RL; Ehrmann DA; Littlejohn EE J Clin Endocrinol Metab; 2015 Apr; 100(4):1537-43. PubMed ID: 25675386 [TBL] [Abstract][Full Text] [Related]
15. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche. Ibáñez L; Valls C; Potau N; Marcos MV; de Zegher F J Clin Endocrinol Metab; 2000 Oct; 85(10):3526-30. PubMed ID: 11061495 [TBL] [Abstract][Full Text] [Related]
16. The risk of functional ovarian hyperandrogenism and polycystic ovary syndrome in patients with hyperandrogenism. Cetinkaya E; Ocal G; Berberoğlu M; Adiyaman P J Pediatr Endocrinol Metab; 2003 Sep; 16(7):1011-6. PubMed ID: 14513878 [TBL] [Abstract][Full Text] [Related]